ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0994

Association Between Cardiovascular Risk Factors and the Onset of Giant Cell Arteritis: A Systematic Review and Meta-analysis

François Barde1, Lucas Pacoureau2, Alexis Elbaz2, Raphaele Seror3 and Yann Nguyen4, 1Inserm, CESP, Paris, France, 2Inserm, CESP, Villejuif, France, 3Service de Rhumatologie, Hôpital Bicêtre, AP-HP, le Kremlin Bicetre, Ile-de-France, France, 4Université Paris Saclay, Clichy, Ile-de-France, France

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, Environmental factors, Epidemiology, giant cell arteritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Giant cell arteritis (GCA) predominantly affects people over 50 years of age, with a female predominance. Its pathophysiological mechanism is currently under debate. In addition to genetic predisposition factors and a positive association between the onset of GCA with previous infections, there are some conflicting arguments for an association with cardiovascular risk factors.
Our aim was to determine whether cardiovascular risk factors are associated with the occurrence of GCA through a systematic literature review with meta-analysis.

Methods: Three authors independently performed a systematic review of Web of Science, PubMed and Embase up to 31 January 2024. PRISMA 2020 guidelines were applied. Studies were included if 1) their design was a case-control study, a cohort study or a cross-sectional study design; 2) the diagnosis of GCA was made by clinicians’ ascertainment, by ACR 1990 criteria, or by ICD-9,-10 code; 3) the diagnosis of a cardiovascular risk factor was based on clinician or biological ascertainment or on coding criteria. Studies with insufficient data to calculate an odds ratio (OR) or hazard ratio (95%CI) were excluded. The ROBINS-E tool (Risk Of Bias [ROB] In Non-randomized Studies – of Exposures) was used to assess bias. Studies assessing the same outcome were eligible for the quantitative analysis using Forrest plots to compare odds ratios (95%CI). The heterogeneity of studies was assessed using I2.

Results: A total of 4,210 citations were identified from the three databases. We excluded 957 duplicated articles and assessed 3,259 articles. A total of 23 studies were included in the qualitative synthesis and 21 in the meta-analysis, with a total of 15,305 GCA cases and 1,879,679 controls.  
 
Twelve studies compared the incidence of GCA in patients with or without diabetes. In our meta-analysis, we found that diabetes was associated with a significant decrease of the risk of GCA (OR 0.70; 95% CI 0.56-0.86). (Figure 1) Similar trend was observed in our sensitivity analyses: when excluding studies with high ROB (OR 0.86; 95% CI 0.71-1.04) and when restricted to studies with ≥ 1 year between exposure and diagnosis of GCA (OR 0.37; 95% CI 0.10-1.41).
 
Compare to normal/low weight, overweight (defined as BMI > 25 kg/m2) was significantly associated with a decreased risk of incident GCA (OR 0.67; 95% 0.46-0.98). By contrast, hypertension was associated with a non-significant increased risk of subsequent GCA (OR 1.22; 95% CI 1.00-1.46).
No significant association was found with dyslipidemia (OR: 1.08, 95% CI 0.83-1.39) or smoking status (OR: 0.97, 95% CI 0.76-1.24). Finally, a personal history of cardiovascular disease was also found to significantly increase the risk of incident GCA (OR 1.2; 95% CI 1.20-1.40), but based on 5 studies with highly unbalanced weights.

Conclusion: This meta-analysis suggests that diabetes and overweight might have a protective effect on the risk of developing GCA, while hypertension tended to be associated with an increased risk of incident GCA.
Our study raises questions about the underlying mechanisms: association with cardiovascular risk factors themselves or with the use of specific medications.
Further prospective studies are needed to evaluate these hypotheses.

Supporting image 1

FIGURE 1. Forrest plot of studies about (A) Diabetes, (B) Hypertension, (C) Overweight, (D) Smoking status, (E) Dyslipidemia, (F) Personal cardiovascular disease


Disclosures: F. Barde: None; L. Pacoureau: None; A. Elbaz: None; R. Seror: Amgen, 6, Boehringer-Ingelheim, 2, Bristol-Myers Squibb(BMS), 2, GlaxoSmithKlein(GSK), 2, Janssen, 2, Pfizer, 6, Roche, 6; Y. Nguyen: None.

To cite this abstract in AMA style:

Barde F, Pacoureau L, Elbaz A, Seror R, Nguyen Y. Association Between Cardiovascular Risk Factors and the Onset of Giant Cell Arteritis: A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/association-between-cardiovascular-risk-factors-and-the-onset-of-giant-cell-arteritis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-cardiovascular-risk-factors-and-the-onset-of-giant-cell-arteritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology